NICE guidance (CG189) sets out a tiered approach to obesity management in the UK
Food & Drug Administration (FDA) announced it will convene the Pharmacy Compounding Advisory Committee (PCAC) on July 23 and 24, 2026, to discuss permitting compounding pharmacies to prepare certain peptides used for ulcerative colitis (UC), wound healing, obesity, insomnia, opioid withdrawal, inflammatory conditions, and osteoporosis, among other conditions
Category 2: Growth Hormone Secretagogue Receptor Agonists (GHRPs and Ghrelin Mimetics) These act on the GHS-R1a (ghrelin) receptor a different receptor from GHRH to amplify GH pulse amplitude and reduce somatostatin tone
The vast majority of data comes from in vivo studies conducted on murine and rat models, as well as in vitro experiments on cell cultures
Helpful nasal peptide resources PT-141 nasal spray guide - Complete PT-141 nasal PT-141 peptide how to use - General PT-141 Semax peptide dosage guide - Semax complete Peptide injections guide - Injection alternative How to reconstitute peptides - Preparation Peptide calculator - Dosing tool In case I dont see you, good afternoon, good evening, and good night
